Chimeric Therapeutics Ltd. (AU:CHM) has launched an replace.
Chimeric Therapeutics Ltd. has reached a major milestone by enrolling the primary participant of their Section...
A $386,000 funding top-up to research why some ovarian most cancers sufferers are treatment-resistant or expertise recurrent most cancers has been dedicated to...